Skip to main content
Withus Pharmaceutical. Co., LTD logo

Withus Pharmaceutical. Co., LTD — Investor Relations & Filings

Ticker · 330350 ISIN · KR7330350000 KO Manufacturing
Open in API
Filings indexed 119 across all filing types
Latest filing 2022-03-10 Proxy Solicitation & In…
Country KR South Korea
Listing KO 330350

About Withus Pharmaceutical. Co., LTD

https://withuspharm.com/

Withus Pharmaceutical. Co., LTD. is a pharmaceutical company engaged in the manufacturing and sale of prescription drugs. The company's product portfolio addresses a range of therapeutic areas, with a focus on circulatory agents, endocrine system treatments, and musculoskeletal drugs. Additionally, its offerings include antibiotics and medications for allergies.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) for Withus Pharmaceutical Co., Ltd. It contains information regarding the upcoming Annual General Meeting (AGM), including the purpose of the meeting, voting procedures (electronic voting/proxy), and financial statements (balance sheet, income statement, etc.) provided as reference materials for shareholders to exercise their voting rights. This aligns perfectly with the definition of a Proxy Solicitation & Information Statement (PSI).
2022-03-10 Korean
주주총회소집공고
AGM Information Classification · 1% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Withus Pharmaceutical Co., Ltd. It contains the agenda for the 18th Annual General Meeting, including reports on financial statements, board appointments, and governance matters. While it contains financial data (balance sheets), this is standard for a proxy statement/notice of meeting in the Korean market to inform shareholders before they vote. It is not an Annual Report (10-K) or an Earnings Release, but rather the official solicitation and notification materials for the AGM.
2022-03-10 Korean
주주총회집중일개최사유신고
AGM Information Classification · 1% confidence The document is a formal notification filed by Withers Pharmaceutical regarding the scheduling of their Annual General Meeting (AGM) on a 'concentrated date' (a date where many companies hold their AGMs). It explains the reasons for this scheduling and mentions the implementation of electronic voting. As it is a regulatory notification regarding meeting logistics rather than the meeting materials themselves or the results, it falls under the general regulatory filing category.
2022-03-02 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 1% confidence The document is a formal announcement from Withers Pharmaceutical regarding the decision to pay a cash dividend. It specifies the dividend amount per share, the total dividend amount, the record date, and the date of the board resolution. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2022-03-02 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Withus Pharmaceutical. It details the date, location, agenda items (such as financial statement approval, director appointments, and remuneration limits), and provides biographical details for the proposed board members. This document is a standard proxy solicitation material sent to shareholders to inform them of the upcoming meeting and request their votes, which fits the definition of a Proxy Solicitation & Information Statement.
2022-03-02 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 1% confidence The document is a regulatory filing from a Korean company (Withus Pharmaceutical) announcing a significant change (over 30%) in revenue and profit structure. This type of disclosure is a standard regulatory requirement in the Korean market (DART system) for material financial events. Since it provides specific financial highlights and reasons for the variance rather than being a full annual report or a simple announcement of a report's availability, it falls under the 'Earnings Release' category as it serves as the initial announcement of financial performance metrics. FY 2021
2022-02-10 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.